Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
Public ClinicalTrials.gov record NCT01764802. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Psychosexual Intervention for Gynecologic and Breast Cancer Patients
Study identification
- NCT ID
- NCT01764802
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Ohio State University Comprehensive Cancer Center
- Other
- Enrollment
- 100 participants
Conditions and interventions
Conditions
- Breast Cancer
- Ovarian Sarcoma
- Ovarian Stromal Cancer
- Stage I Uterine Sarcoma
- Stage I Vaginal Cancer
- Stage I Vulvar Cancer
- Stage IA Cervical Cancer
- Stage IA Endometrial Carcinoma
- Stage IA Fallopian Tube Cancer
- Stage IA Ovarian Epithelial Cancer
- Stage IA Ovarian Germ Cell Tumor
- Stage IA Primary Peritoneal Cavity Cancer
- Stage IB Cervical Cancer
- Stage IB Endometrial Carcinoma
- Stage IB Fallopian Tube Cancer
- Stage IB Ovarian Epithelial Cancer
- Stage IB Ovarian Germ Cell Tumor
- Stage IB Primary Peritoneal Cavity Cancer
- Stage IC Fallopian Tube Cancer
- Stage IC Ovarian Epithelial Cancer
- Stage IC Ovarian Germ Cell Tumor
- Stage IC Primary Peritoneal Cavity Cancer
- Stage II Endometrial Carcinoma
- Stage II Gestational Trophoblastic Tumor
- Stage II Uterine Sarcoma
- Stage II Vaginal Cancer
- Stage II Vulvar Cancer
- Stage IIA Cervical Cancer
- Stage IIA Fallopian Tube Cancer
- Stage IIA Ovarian Epithelial Cancer
- Stage IIA Ovarian Germ Cell Tumor
- Stage IIA Primary Peritoneal Cavity Cancer
- Stage IIB Cervical Cancer
- Stage IIB Fallopian Tube Cancer
- Stage IIB Ovarian Epithelial Cancer
- Stage IIB Ovarian Germ Cell Tumor
- Stage IIB Primary Peritoneal Cavity Cancer
- Stage IIC Fallopian Tube Cancer
- Stage IIC Ovarian Epithelial Cancer
- Stage IIC Ovarian Germ Cell Tumor
- Stage IIC Primary Peritoneal Cavity Cancer
- Stage III Gestational Trophoblastic Tumor
- Stage III Uterine Sarcoma
- Stage III Vaginal Cancer
- Stage III Vulvar Cancer
- Stage IIIA Cervical Cancer
- Stage IIIA Endometrial Carcinoma
- Stage IIIA Fallopian Tube Cancer
- Stage IIIA Ovarian Epithelial Cancer
- Stage IIIA Ovarian Germ Cell Tumor
- Stage IIIA Primary Peritoneal Cavity Cancer
- Stage IIIB Cervical Cancer
- Stage IIIB Endometrial Carcinoma
- Stage IIIB Fallopian Tube Cancer
- Stage IIIB Ovarian Epithelial Cancer
- Stage IIIB Ovarian Germ Cell Tumor
- Stage IIIB Primary Peritoneal Cavity Cancer
- Stage IIIC Endometrial Carcinoma
- Stage IIIC Fallopian Tube Cancer
- Stage IIIC Ovarian Epithelial Cancer
- Stage IIIC Ovarian Germ Cell Tumor
- Stage IIIC Primary Peritoneal Cavity Cancer
Interventions
- behavioral, psychological or informational intervention Other
Other
Eligibility (public fields only)
- Age range
- 21 Years to 80 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2010
- Primary completion
- May 31, 2017
- Completion
- May 31, 2017
- Last update posted
- May 29, 2018
2010 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01764802, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 29, 2018 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01764802 live on ClinicalTrials.gov.